The management of acute ischaemic stroke has been revolutionised by effective reperfusion therapies including thrombolysis and mechanical thrombectomy. In particular, mechanical thrombectomy has heralded a new era in stroke medicine. There have also been developments to improve clinical outcomes for patients who have had an acute ischaemic stroke but are not eligible for this procedure. This article presents an update on the initial management of acute ischaemic stroke, including reperfusion therapies, periprocedural considerations and ongoing research for potential improvements in the care of these patients
The field of acute stroke treatment has made tremendous progress in reducing the overall burden of d...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...
Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-strok...
The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the imp...
The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the imp...
Acute ischemic stroke (AIS) remains a leading cause of death and long-term disability. The paradigms...
Stroke is a major cause of mortality and morbidity, and thrombolysis has served as a catalyst for ma...
Ischemic stroke is a common emergency presentation to hospital with improving survival rates owing t...
Background: Stroke affects one in six people throughout their lifetimes and is the most frequent cau...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Acute ischemic stroke due to large vessel occlusion is a devastating disease. In the vast majority o...
Acute ischaemic stroke is a major public health priority and will become increasingly relevant to ne...
The field of acute stroke treatment has made tremendous progress in reducing the overall burden of d...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...
Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-strok...
The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the imp...
The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the imp...
Acute ischemic stroke (AIS) remains a leading cause of death and long-term disability. The paradigms...
Stroke is a major cause of mortality and morbidity, and thrombolysis has served as a catalyst for ma...
Ischemic stroke is a common emergency presentation to hospital with improving survival rates owing t...
Background: Stroke affects one in six people throughout their lifetimes and is the most frequent cau...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
This article provides a practical overview of current medical treatments for acute ischaemic stroke,...
Acute ischemic stroke due to large vessel occlusion is a devastating disease. In the vast majority o...
Acute ischaemic stroke is a major public health priority and will become increasingly relevant to ne...
The field of acute stroke treatment has made tremendous progress in reducing the overall burden of d...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...
The only effective treatment licensed for acute ischaemic stroke is intravenous thrombolysis within ...